Company / Free Cash Flow per Share
Arrowhead Pharmaceuticals Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.26
FY2025
5-year range
-$5.63 / $1.44
FY2021-FY2025
Trend
+122.4%
vs FY2024
Sector context
#42 of 192
Health Care
What the data says
Arrowhead Pharmaceuticals's free cash flow per share of $1.26 is higher than 78% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $-5.63 in FY2024 to $1.44 in FY2021.
Based on SEC 10-K filings.
1.26 in FY2025. Top quartile in the Health Care sector.
Declined from $1.39 to $1.26 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+106.4% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 122.4% year-over-year.
- Ranks #42 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.26 | +122.4% |
| FY2024 | -$5.63 | -503.9% |
| FY2023 | $1.39 | +235.0% |
| FY2022 | -$1.03 | -171.6% |
| FY2021 | $1.44 | +227.9% |
| FY2020 | -$1.13 | -213.4% |
| FY2019 | -$0.36 | +60.6% |
| FY2018 | -$0.91 | +5.9% |
| FY2017 | -$0.97 | +15.4% |
| FY2016 | -$1.15 | -224.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026